✦ LIBER ✦

Descriptive study of the use of DMARD in patients with Rheumatoid arthritis or persistent arthritis who start drug treatment in Spain (FIRST)

✍ Scribed by Francisco Javier Blanco; Javier Ballina; Jordi Carbonell; Emilio Martín-Mola; Jesús Tornero; Esteban Ramírez; Jordi Galván

Book ID: 119648631
Publisher: Elsevier Science
Year: 2011
Tongue: Spanish
Weight: 341 KB
Volume: 7
Category: Article
ISSN: 2173-5743
DOI: 10.1016/s2173-5743(11)70018-1

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Etanercept in combination with conventio

Etanercept in combination with conventional disease-modifying antirheumatic drugs (DMARDs) in the treatment of rheumatoid arthritis patients intolerant to methotrexate

✍ Yoshinobu Koyama; Hirokazu Shiraishi; Toshiyuki Ohta; Ayumi Uchino 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 350 KB

PAO8 FIRST-YEAR COSTS ASSOCIATED WITH NO

PAO8 FIRST-YEAR COSTS ASSOCIATED WITH NOVEL DISEASE-MODIFYING DRUGS IN THE TREATMENT OF PATIENTS WITH RHEUMATOID ARTHRITIS

✍ D Huse; J Doyle 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 63 KB

Serum undercarboxylated osteocalcin leve

Serum undercarboxylated osteocalcin level increases with 48 weeks of teriparatide treatment in pre-treated elderly rheumatoid arthritis patients who use anti-resorptive drugs

✍ Mokuda, S.; Sawada, N.; Matoba, K.; Yamada, A.; Onishi, M.; Okuda, Y.; Jouyama, 📂 Article 📅 2012 🏛 Springer-Verlag 🌐 English ⚖ 123 KB

Combination therapy with etanercept and

Combination therapy with etanercept and anakinra in the treatment of patients with rheumatoid arthritis who have been treated unsuccessfully with methotrexate

✍ Mark C. Genovese; Stanley Cohen; Larry Moreland; Deborah Lium; Sean Robbins; Ric 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 109 KB 👁 2 views

## Abstract ## Objective To determine the potential for additive or synergistic effects of combination therapy with the selective anti–tumor necrosis factor α agent etanercept and the anti–interleukin‐1 agent anakinra. ## Methods Two hundred forty‐four patients in whom rheumatoid arthritis (RA)

Cost-Effectiveness Analysis of Biologica

Cost-Effectiveness Analysis of Biological Disease-Modifying Antirheumatic Drugs in the Treatment of Russian Patients with Rheumatoid Arthritis Who Failed Previous Anti-Tnf-Alfa Therapy

✍ Ryazhenov, V.V.; Emchenko, I.V. 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 77 KB

Five-year followup of rheumatoid arthrit

Five-year followup of rheumatoid arthritis patients after early treatment with disease-modifying antirheumatic drugs versus treatment according to the pyramid approach in the first year

✍ Suzan M. M. Verstappen; Johannes W. G. Jacobs; Johannes W. J. Bijlsma; Anton H. 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 131 KB 👁 2 views

## Abstract ## Objective To evaluate whether the clinical advantages observed after 1 year in a randomized controlled clinical trial, in which 2 treatment strategies were compared (the early disease‐modifying antirheumatic drug [DMARD] approach versus the pyramid approach), persist after 5 years.